Atlas Trials

Kangabio AUSTRALIA LTD PTY

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kangabio AUSTRALIA LTD PTY

RecordFirmDate
Phase I Study of Single-Agent KGX105 in Patients With Advanced or Metastatic Solid Tumors (NCT07702955)Kangabio AUSTRALIA LTD PTY2026-08-01
A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients (NCT07260305)Kangabio AUSTRALIA LTD PTY2024-11-27
This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors. (NCT06074497)Kangabio AUSTRALIA LTD PTY2023-12-13

Track Kangabio AUSTRALIA LTD PTY automatically

Every clearance here is in the API, with alerts when new ones post.